{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T11:31:27Z","timestamp":1648985487412},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,3,16]],"date-time":"2008-03-16T00:00:00Z","timestamp":1205625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00108-008-2107-y","type":"journal-article","created":{"date-parts":[[2008,3,14]],"date-time":"2008-03-14T06:21:58Z","timestamp":1205475718000},"page":"553-558","source":"Crossref","is-referenced-by-count":0,"title":["Hormontherapie mit \u00d6strogenen und Gestagenen in der Peri- und Postmenopause"],"prefix":"10.1007","volume":"49","author":[{"given":"G.","family":"Emons","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,16]]},"reference":[{"key":"2107_CR1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/aje\/kwm214","volume":"166","author":"Barrett-Connor","year":"2007","unstructured":"Barrett-Connor E (2007) Hormones and heart disease in women: the timing hypothesis. Am J Epidemiol 166: 506\u2013510","journal-title":"Am J Epidemiol"},{"key":"2107_CR2","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte http:\/\/www.bfarm.de\/Presse\/mitteil_2004\/index.php?pv=&more=0410.php"},{"key":"2107_CR3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archinte.166.9.1027","volume":"166","author":"Chen","year":"2006","unstructured":"Chen WY, Manson JE, Hankinson SE et al. (2006) Unopposed estrogen therapy and the risk of invasive breast cancer. Arch Intern Med 166: 1027\u20131032","journal-title":"Arch Intern Med"},{"key":"2107_CR4","unstructured":"Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe im Konsens mit dem Berufsverband der Frauen\u00e4rzte (2006) Konsensusempfehlungen zur Hormontherapie (HT) im Klimakterium und der Postmenopause. http:\/\/www.dggg.de"},{"key":"2107_CR5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1200\/JCO.2005.08.028","volume":"23","author":"Dunn","year":"2005","unstructured":"Dunn BK, Wickerham DL, Ford LG (2005) Prevention of hormone-related cancers: breast cancer. J Clin Oncol 23: 357\u2013367","journal-title":"J Clin Oncol"},{"key":"2107_CR6","first-page":"207","volume":"27","author":"Emons","year":"2004","unstructured":"Emons G, Huschmand-Nia A, Krauss T, Hinney B (2004) Hormone replacement therapy and endometrial cancer. Onkologie 27: 207\u2013210","journal-title":"Onkologie"},{"key":"2107_CR7","first-page":"36","volume":"5","author":"Emons","year":"2006","unstructured":"Emons G (2006) Hormonsubstitution bei Frauen in der Postmenopause. Kassenarzt 5: 36\u201340","journal-title":"Kassenarzt"},{"key":"2107_CR8","first-page":"430","volume":"47","author":"Emons","year":"2006","unstructured":"Emons G (2006) Sind \u00d6strogene Karzinogene? Frauenarzt 47: 430\u2013435","journal-title":"Frauenarzt"},{"key":"2107_CR9","first-page":"CD004143","volume":"3","author":"Farquhar","year":"2005","unstructured":"Farquhar CM, Marjoribanks J, Lethaby A et al. the Cochrane HT Study Group (2005) Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 3: CD004143","journal-title":"Cochrane Database Syst Rev"},{"key":"2107_CR10","unstructured":"Gemeinsames Krebsregister der L\u00e4nder Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen-Anhalt und der Freistaaten Sachsen und Th\u00fcringen (2007) Brustkrebsinzidenz bei 45\u201359-j\u00e4hrigen Frauen r\u00fcckl\u00e4ufig. http:\/\/www.berlin.de\/gkr"},{"key":"2107_CR11","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/jnci\/djm059","volume":"99","author":"Glass","year":"2007","unstructured":"Glass AG, Lacey JV, Carreon JD, Hoover RN (2007) Breast cancer incidence, 1980\u20132006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99: 1152\u20131161","journal-title":"J Natl Cancer Inst"},{"key":"2107_CR12","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","volume":"117","author":"Grady","year":"1992","unstructured":"Grady D, Rubin SM, Petiti DB et al. (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016\u20131037","journal-title":"Ann Intern Med"},{"key":"2107_CR13","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMcp054015","volume":"355","author":"Grady","year":"2006","unstructured":"Grady D (2006) Management of menopausal symptoms. N Engl J Med 355: 2338\u20132347","journal-title":"N Engl J Med"},{"key":"2107_CR14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","volume":"280","author":"Hulley","year":"1998","unstructured":"Hulley S, Grady D, Bush T et al. (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605\u2013613","journal-title":"JAMA"},{"key":"2107_CR15","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/bcr1672","volume":"9","author":"Jemal","year":"2007","unstructured":"Jemal A, Ward E, Thun MJ ( 2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9: R28","journal-title":"Breast Cancer Res"},{"key":"2107_CR16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-007-9566-z","volume":"107","author":"Katalinic","year":"2008","unstructured":"Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 107: 427\u2013430","journal-title":"Breast Cancer Res Treat"},{"key":"2107_CR17","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1212\/01.wnl.0000277275.42504.93","volume":"69","author":"Maki","year":"2007","unstructured":"Maki PM, Gast MJ, Vieweg AJ et al. (2007) Hormone therapy in menopausal women with cognitive complaints: a randomized, double-blind trial. Neurology 69: 1322\u20131330","journal-title":"Neurology"},{"key":"2107_CR18","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","volume":"356","author":"Manson","year":"2007","unstructured":"Manson JE, Allison MA, Rossouw JE et al. (2007) Estrogen therapy and coronary-artery calcification. N Eng J Med 356: 2591\u20132602","journal-title":"N Eng J Med"},{"key":"2107_CR19","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","volume":"365","author":"Million","year":"2005","unstructured":"Million Women Study Collaborators (2005) Endometrial cancer and hormone replacement therapy in the Million Women Study. Lancet 365: 1543\u20131551","journal-title":"Lancet"},{"key":"2107_CR20","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","volume":"369","author":"Million","year":"2007","unstructured":"Million Women Study Collaborators (2007) Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 369: 1703\u20131710","journal-title":"Lancet"},{"key":"2107_CR21","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archinte.166.14.1453","volume":"166","author":"Nedrow","year":"2006","unstructured":"Nedrow A, Miller J, Walker M et al. (2006) Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 166: 1453\u20131465","journal-title":"Arch Intern Med"},{"key":"2107_CR22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/gme.0b013e31803167ab","volume":"14","author":"North","year":"2007","unstructured":"North American Menopause Society (2007) Estrogen and progesteron use in peri- and postmenopausal women: March 2007 position statement of the North American Menopause Society. Menopause 14: 168\u2013182","journal-title":"Menopause"},{"key":"2107_CR23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13697130701361657","volume":"10","author":"Pines","year":"2007","unstructured":"Pines A, Sturdee DW, Birkh\u00e4user MH et al. (2007) IMS updated recommendations on postmenopausal hormone therapy. Climacteric 10: 181\u2013194","journal-title":"Climacteric"},{"key":"2107_CR24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJMsr070105","volume":"356","author":"Ravdin","year":"2007","unstructured":"Ravdin PM, Cronin KA, Howlader N et al. (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356: 1670\u20131674","journal-title":"N Engl J Med"},{"key":"2107_CR25","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1200\/JCO.2007.11.4132","volume":"25","author":"Robbins","year":"2007","unstructured":"Robbins AS, Clarke CA (2007) Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol 25: 3437\u20133439","journal-title":"J Clin Oncol"},{"key":"2107_CR26","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","volume":"297","author":"Rossouw","year":"2007","unstructured":"Rossouw JE, Prentice RL, Manson JE et al. (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297: 1465\u20131477","journal-title":"JAMA"},{"key":"2107_CR27","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/01.gme.0000184221.63459.e1","volume":"12","author":"Shah","year":"2005","unstructured":"Shah NR, Borenstein J, Dubois RW (2005) Postmenopausal hormone therapy and breast cancer: a systematic review and metaanalysis. Menopause 12: 668\u2013678","journal-title":"Menopause"},{"key":"2107_CR28","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1001\/jama.295.14.1647","volume":"295","author":"Stefanick","year":"2006","unstructured":"Stefanick ML, Anderson GL, Margolis KL et al. (2006) Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 295: 1647\u20131657","journal-title":"JAMA"},{"key":"2107_CR29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10304-007-0194-9","volume":"5","author":"Wiegratz","year":"2007","unstructured":"Wiegratz I, Kuhl H (2007) Praxis der Hormontherapie in der Peri- und Postmenopause. Gynakol Endokrinol 5: 141\u2013149","journal-title":"Gynakol Endokrinol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2107-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-008-2107-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-008-2107-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:12:08Z","timestamp":1558570328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-008-2107-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,16]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["2107"],"URL":"https:\/\/doi.org\/10.1007\/s00108-008-2107-y","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,16]]}}}